Multicomponent Reaction-Based Heteroannulations: A Direct Access to Fused Tetrazolo Piperazinones and 1,4-Diazepanones

Eirini Fotopoulou; Alexandros Vasilakis; Constantinos G. Neochoritis

doi:10.1055/a-2239-6897

Synlett, Table of Contents

Synlett 2024; 35(15): 1828-1832
DOI: 10.1055/a-2239-6897

letter

14th EuCheMS Young Investigators Workshop

Multicomponent Reaction-Based Heteroannulations: A Direct Access to Fused Tetrazolo Piperazinones and 1,4-Diazepanones

Authors

Eirini Fotopoulou
Alexandros Vasilakis
Constantinos G. Neochoritis ∗

Abstract

All articles of this category

Abstract

By exploiting the chemistry of bifunctional isocyanides, straightforward, rapid, and scalable Ugi-tetrazole-based multicomponent reaction heteroannulations were developed. Our synthetic approach provides a series of diverse fused tetrazolo piperazinones and 1,4-diazepanones in just one step.

Key words

isocyanides - tetrazoles - piperazinones - diazepanones - Ugi reaction - multicomponent reaction

Full Text

References

References and Notes
1 Dandapani S, Rosse G, Southall N, Salvino JM, Thomas CJ. Curr. Protoc. Chem. Biol. 2012; 4: 177
2 van Vlijmen H, Ortholand J.-Y, Li VM.-J, de Vlieger JS. B. Drug Discovery Today 2021; 26: 2406
3 Saha A, Varghese T, Liu A, Allen SJ, Mirzadegan T, Hack MD. J. Chem. Inf. Model. 2018; 58: 2057
4 Wigglesworth MJ, Murray DC, Blackett CJ, Kossenjans M, Nissink JW. M. Curr. Opin. Chem. Biol. 2015; 26: 104
5 Dahlin JL, Walters MA. Future Med. Chem. 2014; 6: 1265
6 Glick M, Jacoby E. Curr. Opin. Chem. Biol. 2011; 15: 540
7 Kerru N, Gummidi L, Maddila S, Gangu KK, Jonnalagadda SB. Molecules 2020; 25: 1909
8 Amin A, Qadir T, Sharma PK, Jeelani I, Abe H. Open Med. Chem. J. 2022; 16: e187410452209010
9 Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM. L, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD. J. Med. Chem. 2007; 50: 6706
10 Powell NA, Ciske FL, Clay EC, Cody WL, Downing DM, Blazecka PG, Holsworth DD, Edmunds JJ. Org. Lett. 2004; 6: 4069
11 El Kaim L, Gageat M, Gaultier L, Grimaud L. Synlett 2007; 500
12 Hulme C, Peng J, Louridas B, Menard P, Krolikowski P, Kumar NV. Tetrahedron Lett. 1998; 39: 8047
13 Hulme C, Cherrier M.-P. Tetrahedron Lett. 1999; 40: 5295
14 Hulme C, Ma L, Kumar NV, Krolikowski PH, Allen AC, Labaudiniere R. Tetrahedron Lett. 2000; 41: 1509
15 Abelman MM, Fisher KJ, Doerffler EM, Edwards PJ. Tetrahedron Lett. 2003; 44: 1823
16 Gellerman G, Hazan E, Kovaliov M, Albeck A, Shatzmiler S. Tetrahedron 2009; 65: 1389
17 Vaňková B, Brulíková L, Wu B, Krchňák V. Eur. J. Org. Chem. 2012; 5075
18 Ben Haj Salah K, Legrand B, Bibian M, Wenger E, Fehrentz J.-A, Denoyelle S. Org. Lett. 2018; 20: 3250
19 Wang W, Ollio S, Herdtweck E, Dömling A. J. Org. Chem. 2011; 76: 637
20 Pérez-Martín C, Rebolledo F, Brieva R. Adv. Synth. Catal. 2022; 364: 1326
21 Biftu T, Feng D, Qian X, Liang G.-B, Kieczykowski G, Eiermann G, He H, Leiting B, Lyons K, Petrov A, Sinha-Roy R, Zhang B, Scapin G, Patel S, Gao Y.-D, Singh S, Wu J, Zhang X, Thornberry NA, Weber AE. Bioorg. Med. Chem. Lett. 2007; 17: 49
22 Mravljak J, Monasson O, Al-Dabbagh B, Crouvoisier M, Bouhss A, Gravier-Pelletier C, Le Merrer Y. Eur. J. Med. Chem. 2011; 46: 1582
23 Gravier-Pelletier C, Charvet I, Le Merrer Y, Depezay J.-C. J. Carbohydr. Chem. 1997; 16: 129
24 Wang S, Wang S, Song S, Gao Q, Wen C, Zhang Z, Zheng L, Xiang J. J. Org. Chem. 2021; 86: 6458
25 Medda F, Martinez-Ariza G, Hulme C. Tetrahedron Lett. 2015; 56: 5295
26 Staniszewska M, Zdrojewski T, Gizińska M, Rogalska M, Kuryk Ł, Kowalkowska A, Łukowska-Chojnacka E. Eur. J. Med. Chem. 2022; 230: 114060
27 Farhid H, Khodkari V, Nazeri MT, Javanbakht S, Shaabani A. Org. Biomol. Chem. 2021; 19: 3318
28 Lecointre B, Narozny R, Borrello MT, Senger J, Chakrabarti A, Jung M, Marek M, Romier C, Melesina J, Sippl W, Bischoff L, Ganesan A. Philos. Trans. R. Soc., B 2018; 373: 20170364
29 Hulme C, Ma L, Cherrier M.-P, Romano JJ, Morton G, Duquenne C, Salvino J, Labaudiniere R. Tetrahedron Lett. 2000; 41: 1883
30 Shi L, Wen M, Li F. Chin. J. Chem. 2021; 39: 317
31 Heravi MM, Zadsirjan V. RSC Adv. 2020; 10: 44247
32 Vitaku E, Smith DT, Njardarson JT. J. Med. Chem. 2014; 57: 10257
33 Neochoritis CG, Zhao T, Dömling A. Chem. Rev. 2019; 119: 1970
34 Nixey T, Kelly M, Hulme C. Tetrahedron Lett. 2000; 41: 8729
35 Akritopoulou-Zanze I, Gracias V, Djuric SW. Tetrahedron Lett. 2004; 45: 8439
36 Umkehrer M, Kolb J, Burdack C, Ross G, Hiller W. Tetrahedron Lett. 2004; 45: 6421
37 Hulme C, Morrissette MM, Volz FA, Burns CJ. Tetrahedron Lett. 1998; 39: 1113
38 Dömling A, Huang Y. Synthesis 2010; 2859
39 Gao L, Shaabani S, Reyes Romero A, Xu R, Ahmadianmoghaddam M, Dömling A. Green Chem. 2023; 25: 1380
40 Zarganes-Tzitzikas T, Patil P, Khoury K, Herdtweck E, Dömling A. Eur. J. Org. Chem. 2015; 2015: 51
41 Patil P, Kurpiewska K, Kalinowska-Tłuścik J, Dömling A. ACS Comb. Sci. 2017; 19: 343
42 Wang Y, Patil P, Kurpiewska K, Kalinowska-Tłuścik J, Dömling A. ACS Comb. Sci. 2017; 19: 193
43 Nixey T, Kelly M, Semin D, Hulme C. Tetrahedron Lett. 2002; 43: 3681
44 Nayak M, Batra S. Tetrahedron Lett. 2010; 51: 510
45 Borisov RS, Polyakov AI, Medvedeva LA, Khrustalev VN, Guranova NI, Voskressensky LG. Org. Lett. 2010; 12: 3894
46 Yerande SG, Newase KM, Singh B, Boltjes A, Dömling A. Tetrahedron Lett. 2014; 55: 3263
47 Fragkiadakis M, Anastasiou P.-K, Zingiridis M, Triantafyllou-Rundell ME, Reyes Romero A, Stoumpos CC, Neochoritis CG. J. Org. Chem. 2023; 88: 12709
48 Fragkiadakis M, Neochoritis CG. Synlett 2022; 33: 1913
49 Zarganes-Tzitzikas T, Chandgude AL, Dömling A. Chem. Rec. 2015; 15: 981
50 Lipinski CA. Drug Discovery Today: Technol. 2004; 1: 337
51 Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Adv. Drug Delivery Rev. 2001; 46: 3
52 Ugi-Tetrazole Four-Component Synthesis of 10a–k; General Procedure The aldehyde (1.0 mmol) was added to a stirred solution of the amine (1.0 mmol) and Et₃N (1.0 mmol) in MeOH (1.0 mL), and the mixture was stirred for 10 min. The isocyanide 9 (1.0 mmol) and TMSN₃ (1.0 mmol) were then added, and the mixture was stirred vigorously for 48 h at 40 °C. The solvent was removed under reduced pressure, and the residue was purified by column chromatography [silica gel, PE–EtOAc (5:1 to 1:1)].
53 Ethyl 3-(4-Cyclopropyl-9-methyl-6-oxo-4H-tetrazolo[1,5-a]thieno[2,3-f][1,4]diazepin-5(6H)-yl)propanoate (10a) Yellow oil; yield: 157 mg (51%). ¹H NMR (500 MHz, CDCl₃): δ = 7.37–7.33 (d, J = 19.5 Hz, 1 H), 4.10–4.06 (m, 1 H), 3.70–3.68 (d, J = 7.5 Hz, 3 H), 3.64–3.61 (d, J = 12.9 Hz, 2 H), 3.15–3.12 (m, 1 H), 2.45–2.43 (m, 1 H), 2.34–2.30 (m, 1 H), 2.00–1.94 (d, J = 16.1 Hz, 3 H), 1.13–0.95 (m, 1 H), 0.63–0.47 (m, 1 H), 0.33–0.31 (m, 1 H), 0.15–0.13 (m, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 173.0, 160.1, 158.6, 157.8, 136.9, 134.1, 127.2, 60.5, 58.1, 52.7, 51.7, 43.0, 34.6, 15.6, 13.3, 4.3, 3.3, 2.9. HRMS (ESI): m/z [M + CH₃OH]⁺ calcd for C₁₇H₂₃N₅O₄S: 394.1514; found: 394.1547. Ethyl [8-(4-Chlorophenyl)-6-oxo-5,6-dihydrotetrazolo[1,5-a]pyrazin-7(8H)-yl]acetate (10i) Yellow oil; yield: 162 mg (57%). ¹H NMR (500 MHz, CDCl₃): δ = 7.42–7.40 (m, 2 H), 7.26–7.25 (m, 2 H), 6.13 (s, 1 H), 5.31–5.26 (m, 2 H), 4.75–4.71 (d, J = 17.5 Hz, 1 H), 4.19–4.17 (m, 2 H), 3.54–3.50 (d, J = 17.5 Hz, 1 H), 1.26–1.24 (m, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 167.6, 161.6, 149.6, 136.1, 132.9, 129.9, 128.9, 61.9, 57.3, 47.8, 45.9, 13.9. HRMS (ESI): m/z [M + H]⁺ calcd for C₁₄H₁₅ClN₅O₃: 336.0842; found: 336.0856.

Supplementary Material

Supporting Information (PDF) (opens in new window)